Allan Kirk PhD - 02 Oct 2023 Form 3 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for Allan Kirk, M.D., PhD
Issuer symbol
ELDN
Transactions as of
02 Oct 2023
Net transactions value
$0
Form type
3
Filing time
02 Oct 2023, 17:08:23 UTC
Next filing
13 Jan 2025

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney No securities beneficially owned.